Effect of chemotherapy preoperatively upon early postoperative cognitive dysfunction in eldly tumor patients

National Medical Journal of China

Volumn 89, Issue 33, 2009, Pages 2319-2323

  Fang, Jun ^a   Cai, Shu Nv ^a   Jiang, Hui Fang ^a   Zhou, Hui Dan ^a   Lian, Yan Hong ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Anesthesia; Chemotherapy; Cognitive dysfunction; Eldly; Tumor

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INTESTINE TUMOR; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PREMEDICATION; PSYCHOLOGICAL ASPECT; STOMACH TUMOR;

AGED; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FEMALE; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREMEDICATION; STOMACH NEOPLASMS;

EID: 84871416224     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.33.005     Document Type: Article

References (22)

1. Xie Z, Tanzi RE. Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol, 2006,41:346-359.
2. Newman S, Stygall J, Hirani S, et al. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology 2007, 106: 572-590.
3. AbildstromH, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand, 2000, 44: 1246-1251.
4. Silberfarb PM, Philibert D, Levine PM. Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry, 1980,137: 597-601.
5. Vardy J, Wefel JS, Ahles T, et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol, 2008,19: 623-629.
6. Murkin JM, Newman SP, Stump DA, et al. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg, 1995, 59: 1289-1295.
7. Silbert BS, Scott DA, Evered LA, et al. A comparison of the effect of high-and low-dose fentanyl on the incidence of postoperative cognitive dysfunction after coronary artery bypass surgery in the elderly. Anesthesiology, 2006,104; 1137-1145.
8. Hess LM, Insel KC. Chemotherapy-related change in cognitive function; a conceptual model. Oncol Nurs Forum, 2007,34: 981-994.
9. Lewis MS, Maruff P, Silbert BS, et al. The sensitivity and specificity of three common statistical rules for the classification of post-operative cognitive dysfunction following coronary artery bypass graft surgery. Acta Anaesthesiol Scand, 2006, 50: 50-57.
10. Tanzi RE. The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci, 2005, 8: 977-979.
11. Lelis RG, Krieger JE, Pereira AC, et al. Apolipoprotein E4 genotype increases the risk of postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery. J Cardiovasc Surg(Torino) , 2006,47: 451-456.
12. Lou MF, Yu PJ, Huang GS, et al. Predicting post-surgical cognitive disturbance in older Taiwanese patients. Int J Nurs Stud, 2004,41: 2941.
13. Hurria A, Rosen C, Hudis C, et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer; a pilot prospective longitudinal study. J Am Geriatr Soc, 2006 , 54: 925-931.
14. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care, 2007 ,5 :273-280.
15. Dietrich J, Monje M, Wefel J, et al. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist, 2008, 13 :1285-1295.
16. Mignone RG, Weber ET. Potent inhibition of cell proliferation in the hippo-campal dentate gyrus of mice by the chemotherapeutic drug thioTEPA. Brain Res, 2006, 1111: 26-29.
17. Seigers R, Schagen SB, Beerling W, et al. Long-lasting suppression of hippocam-pal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res, 2008,186: 168-175.
18. Inagaki M, Yoshikawa E, Matsuoka Y, et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 2007,109:146-156.
19. Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat, 2007,103 :303-311.
20. Grocott HP. Hyperglycemia and postoperative cognitive dysfunction; another call for better glycemic control? Can J Anaesth, 2008,55: 140-145.
21. Wang Y, Sands LP, Vaurio L, et al. The effects of postoperative pain and its management on postoperative cognitive dysfunction. Am J Geriatr Psychiatry, 2007 ,15:50-59.
22. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med, 2003, 348: 2110-2124.